How has Crinetics Pharmaceuticals's change in deferred revenue changed year-over-year?

Crinetics Pharmaceuticals's change in deferred revenue decreased by 18.6% year-over-year, from -$361K to -$428K.

What does change in deferred revenue mean?

Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.

Crinetics Pharmaceuticals CRNX Change in Deferred Revenue

Change in Deferred Revenue at other companies

Rhythm Pharmaceuticals, Inc.RYTM

-$145K+88.7%

BridgeBio PharmaBBIO

-$2.38M+7.5%

Arrowhead ResearchARWR

$163.36M—

ALN

Alnylam PharmaceuticalsALNY

-$1.63M+94.0%

PTC TherapeuticsPTCT

-$1.52M-121%

Protagonist TherapeuticsPTGX

-$3.27M+40.5%

Other financials

Income statement

See full

Revenue$10.7M+2,873%

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.78B+21.9%

Enterprise value$3.71B+21.5%

P/S209.3×-3,875×

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's change in deferred revenue?: Crinetics Pharmaceuticals (CRNX) reported change in deferred revenue of -$428K in Q1 2026.
How has Crinetics Pharmaceuticals's change in deferred revenue changed year-over-year?: Crinetics Pharmaceuticals's change in deferred revenue decreased by 18.6% year-over-year, from -$361K to -$428K.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.